Medical marijuana dispensary to set for soft opening this week
Ahead of severe winter weather, many people stock up on groceries like milk and bread. Those with certain health needs will be able to make another stop however before weekend snow hits. Sanjay Patel …
Cannabis M&A Didn’t Vanish. It’s Just Not Happening In Public
Despite talk of a deal drought, consolidation continues through private transactions, credit structures and asset-level acquisitions.
Michigan’s cannabis market heads into a year of upheaval
Michigan’s cannabis market is one of the largest markets in the country by volume. A 24% tax on marijuana threatens to disrupt this growth.
Trump’s Cannabis Rescheduling Order Could Finally Kill A Crushing Tax Rule And Transform US Weed Stocks, Says Expert
Dan Ahrens analyzes Trump’s historic cannabis shift. Learn how Schedule 3 could end the 280E “narcotics trafficker” tax for US pot stocks.
MSOS ETF drops 26% in one month as federal cannabis policy stalls
Quick Read AdvisorShares Pure US Cannabis ETF (MSOS) dropped 26% to $4.80 by mid-January despite Trump’s December executive order. MSOS holds $921M and gains exposure to Curaleaf and Trulieve through …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
As Trump looks at reclassifying cannabis, NH governor says state law won’t change
President Donald Trump is signaling that potential changes could be coming on cannabis at the federal level, but Gov. Kelly Ayotte said any developments in Washington wouldn’t change her outlook on …
Tilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting Narrative
Tilray surges 92% in 3 days amid marijuana rescheduling buzz. Discover how this impacts cannabis stocks and potential investor opportunities.
Why Curaleaf Stock Rocked the Market Today
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182 % for the S&P 500. Don’t miss out on the latest top 10 list, available when you …
Rescheduling Should Send MJ And MSOS Sky High
Cannabis ETFs MJ and MSOS are surging on rescheduling speculation that Trump will reclassify marijuana as a Schedule III drug. Read why I rate them as Buy.
CBD Oils: Do You Know What’s Inside?
Farm Bill effectively legalized hemp-derived CBD, there’s been an exponential growth in products hitting the market, but a newly published study suggests consumer understanding of the products has not …
Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that a divisional …
cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval
FSA Publishes Safety Assessment for cbdMD’s Proprietary CBD IngredientCharlotte, North Carolina–(Newsfile Corp. – April 7, 2025) – cbdMD, Inc.
CBD of Denver Expands Into the Tech Sector with Strategic LOI Signing
Detailed price information for Cbd of Denver Inc (CBDD) from The Globe and Mail including charting and trades.
Truck driver can seek triple damages in lawsuit over THC content in CBD product, Supreme Court says
WASHINGTON (AP) — The Supreme Court on Wednesday sided with a truck driver who wants to sue for triple damages over a CBD hemp product he says was falsely … in US South after dayslong deluge of rain …
Recent Comments